The association between cystatin C and incident type 2 diabetes is related to central adiposity

Nephrology Dialysis Transplantation

Volumn 28, Issue 7, 2013, Pages 1820-1829

  Reutens, Anne T ^a,b   Bonnet, Fabrice ^c,d   Lantieri, Olivier ^e   Roussel, Ronan ^f,g,h   Balkau, Beverley ^a,i,j  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITÉ DE RENNES 1   (France)

^d Univ Rennes   (France)

^e La Riche   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g BICHAT HOSPITAL   (France)

^h CENTRE DE RECHERCHE DES CORDELIERS   (France)

ⁱ CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^j University of Paris   (France)

more..

Author keywords

Adiposity; Cystatin C; Diabetes; Epidemiology; Incidence

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; VALIDATION PROCESS; WAIST CIRCUMFERENCE;

ADIPOSITY; CYSTATIN C; DIABETES; EPIDEMIOLOGY; INCIDENCE;

ADIPOSITY; ANTHROPOMETRY; BIOLOGICAL MARKERS; COHORT STUDIES; CYSTATIN C; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; INSULIN RESISTANCE; KIDNEY FUNCTION TESTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 84884513845     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs561     Document Type: Article

References (29)

1. Dharnidharka V, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226
2. Roos J, Doust J, Tett S et al. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children: a meta-analysis. Clin Biochem 2007; 40: 383-391
3. Turk V, BodeW. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991; 285: 213-219
4. Sahakyan K, Lee K, Shankar A et al. Serum cystatin C and the incidence of type 2 diabetes mellitus. Diabetologia 2011; 54: 1335-1340
5. Donahue R, Stranges S, Rejman K et al. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care 2007; 30: 1724-1729
6. Knight E, Verhave J, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65: 1416-1421
7. Parikh N, Hwang S, Yang Q et al. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 2008; 102: 1194-1198
8. Shankar A, Teppala S. Relationship between body mass index and high cystatin levels among US adults. J Clin Hypertens (Greenwich) 2011; 13: 925-930
9. Muntner P, Winston J, Uribarri J et al. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008; 121: 341-348
10. Servais A, Giral P, Bernard M et al. Is serum cystatin-C a reliable marker for metabolic syndrome? Am J Med 2008; 121: 426-432
11. Surendar J, Indulekha K, Aravindhan V et al. Association of cystatin-C with metabolic syndrome in normal glucosetolerant subjects (CURES-97). Diabetes Technol Ther 2010; 12: 907-912
12. Lee S, Park S, Ko S et al. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients. Metabolism 2010; 59: 241-246
13. Retnakaran R, Connelly P, Harris S et al. Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. Pediatr Nephrol 2007; 22: 1007-1013
14. Naour N, Fellahi S, Renucci J et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009; 17: 2121-2126
15. Balkau B, Lange C, Fezeu L et al. Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2008; 31: 2056-2061
16. Diabetes Trials Unit. HOMA insulin sensitivity and insulin secretion calculator. http://www.dtu.ox.ac.uk/homacalculator/index.php (21 April 2011, date last accessed)
17. Wallace T, Levy J, Matthews D. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266
19. Grundy S, Cleeman J, Daniels S et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
20. Young J, Hwang S, Sarnak M et al. Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 2008; 3: 1786-1791
21. Hooton H, Dubern B, Henegar C et al. Association between CST3 rs2424577 polymorphism and corpulence related phenotypes during lifetime in populations of European ancestry. Obes Facts 2011; 4: 131-144
22. Lafarge J, Naour N, Clément K et al. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2010; 92: 1580-1586
23. Lorenzo C, Nath S, Hanley A et al. Risk of type 2 diabetes among individuals with high and low glomerular filtration rates. Diabetologia 2009; 52: 1290-1297
24. Okada R, Yasuda Y, Tsushita K et al. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 2012; 27: 1821-1825
25. Thomas G, Sehgal A, Kashyap S et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011; 6: 2364-2373
26. Burton J, Gray L, Webb D et al. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population. Nephrol Dial Transplant 2012; 27: 1860-1866
27. Nerpin E, Risérus U, Ingelsson E et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 2008; 31: 1550-1555
28. Sarafidis P, Ruilope L. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006; 26: 232-244
29. Vaxillaire M, Veslot J, Dina C et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 2008; 57: 244-254